Does Microvolt T-Wave Alternans Testing Predict Ventricular Tachyarrhythmias in Patients With Ischemic Cardiomyopathy and Prophylactic Defibrillators?. The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) Trial

Journal of the American College of Cardiology

Volumn 52, Issue 20, 2008, Pages 1607-1615

  Chow, Theodore ^a   Kereiakes, Dean J ^a   Onufer, John ^b   Woelfel, Alan ^c   Gursoy, Sinan ^d   Peterson, Brett J ^e   Brown, Mark L ^e   Pu, Wenji ^e   Benditt, David G ^f  

^a The Carl & Edyth Lindner Center for Research & Education   (United States)

^b Cardiovascular Associates Ltd   (United States)

^c West Michigan Orthopaedics   (United States)

^d Naples Community Hospital Healthcare System   (United States)

^e MEDTRONIC INC   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

defibrillator therapy; risk stratification; sudden death; T wave alternans; ventricular arrhythmias

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; T WAVE; UNITED STATES;

AGED; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR;

EID: 55049088260     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.08.018     Document Type: Article

References (29)

1. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
2. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
3. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomised study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 (1999) 1882-1890
4. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 (1996) 1933-1940
5. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics-2008 update. Circulation 177 (2008) e25-e146
6. Zwanziger J., Hall W., Dick A., et al. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 47 (2006) 2310-2318
7. Gehi A.K., Stein R.H., Metz L.D., and Gomes J.A. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 46 (2005) 75-82
8. Ikeda T., Saito H., Tanno K., et al. T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. Am J Cardiol 89 (2002) 79-82
9. Chow T., Kereiakes D.J., Bartone C., et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1820-1827
10. Bloomfield D.M., Bigger J.T., Steinman R.C., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
11. Gregoratos G., Abrams J., Epstein A.E., et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrythmia devices-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 40 (2002) 1703-1719
12. Bloomfield D.M., Hohnloser S.H., and Cohen R.J. Interpretation and classification of microvolt T wave alternans tests. J Cardiovasc Electrophysiol 13 (2002) 502-512
13. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
14. Cox D.R. Regression models and life tables. J Roy Stat Soc B 34 (1972) 187-220
15. Kaufman E.F., Bloomfield D.M., Steinman R.C., et al. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 48 (2006) 1399-1404
16. Bloomfield D.M., Steinman R.C., Namerow P.B., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110 (2004) 1885-1889
17. Hohnloser S.H., Ikeda T., Bloomfield D.M., Dabbous O.H., and Cohen R.J. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet 362 (2003) 125-126
18. Chow T., Kereiakes D.J., Bartone C., et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 49 (2007) 50-58
19. Gold M.R., Ensley D., Chilson D., et al. T-wave alternans SCD HeFT study: primary endpoint analysis. (abstr). Circulation 114 (2006) II428
20. Bloch-Thomsen P.E., HuiKuri H.V., and CARISMA Investigators. Cardiac Arrhythmias and Risk Stratification in Patients with Low Ejection Fraction after Acute Myocardial Infarction: The CARISMA Study. (abstr) (2007) Paper presented at: Heart Rhythm Society Scientific Sessions; May 10; Denver, CO
21. Costantini O., Rosenbaum D.S., Hohnloser S.H., et al., ABCD Investigators. The Alternans Before Cardioverter Defibrillator (ABCD) Trial: a noninvasive strategy for primary prevention of sudden cardiac death using T-wave alternans. (abstr). Circulation 114 (2006) 2426
22. Cantillon D.J., Stein K.M., Markowitz S.M., et al. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction. J Am Coll Cardiol 50 (2007) 166-173
23. Rashba E.J., Osman A.F., MacMurdy K., et al. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol 15 (2004) 170-176
24. Salerno-Uriarte J.A., De Ferrari G.M., Klersy C., et al. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA study. J Am Coll Cardiol 50 (2007) 1896-1904
25. Sweeney M.O., Ruetz L.L., Belk P., Mullen T.J., Johnson J.W., and Sheldon T. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia?. J Am Coll Cardiol 50 (2007) 614-622
26. Rashba E.J., Osman A.F., MacMurdy K., et al. Influence of QRS duration on the prognostic value of T wave alternans. J Cardiovasc Electrophysiol 13 (2002) 770-775
27. Rashba E.J., Cooklin M., MacMurdy K., et al. Effects of selective autonomic blockade on T-wave alternans in humans. Circulation 105 (2002) 837-842
28. Ikeda T., Yoshino H., Sugi K., et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction. J Am Coll Cardiol 48 (2006) 2268-2274
29. Ellenbogen K.A., Levine J.H., Berger R.D., et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?. Circulation 113 (2006) 776-782